CJC-1295 vs MK-677 Which Better Comparison: Applications and Research Goals
Mechanism of Action GHRH receptor agonist; amplifies endogenous GH pulses via extended GHRH signaling Ghrelin mimetic; stimulates continuous GH secretion independent of GHRH pathway CJC-1295 preserves natural pulsatility; MK-677 produces sustained elevation Ha
This comparison does not assign a generated winner or score.
- Mechanism of Action
- GHRH receptor agonist; amplifies endogenous GH pulses via extended GHRH signaling
- Ghrelin mimetic; stimulates continuous GH secretion independent of GHRH pathway
- CJC-1295 preserves natural pulsatility; MK-677 produces sustained elevation
- Half-Life
- 6–8 days (with DAC modification)
- 4–6 hours
- CJC-1295 requires weekly dosing; MK-677 requires daily dosing
- Administration Route
- Subcutaneous injection (reconstituted peptide)
- Oral capsule or liquid
- MK-677 is more convenient; CJC-1295 requires injection training
- IGF-1 Response
- Pulsatile elevation (1.5–3× baseline at peak, cycling over 7–9 days)
- Sustained elevation (60% above baseline, plateaus after 2–4 weeks)
- CJC-1295 mimics natural patterns; MK-677 produces steady-state elevation
- Primary Side Effects
- Injection-site reactions, potential for joint pain and fluid retention at high doses
- Increased appetite, water retention, modest blood glucose elevation
- MK-677's side effects are systemic and metabolic; CJC-1295's are localized and dose-dependent
- Storage Requirements
- Refrigeration required (2–8°C post-reconstitution, use within 28 days)
- Stable at room temperature in capsule form
- MK-677 is logistically simpler for long-term protocols
- Research Applications
- Models requiring natural GH pulsatility, feedback loop studies, long-term receptor sensitivity research
- Models studying sustained GH elevation, appetite regulation, continuous anabolic effects
- Choose based on whether the research question requires pulsatile or sustained GH patterns